Optimi Health Adds to Corporate and Advisory Team
April 14, 2021 09:00 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, April 14, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional...
Optimi Health Aims to Expand its Shareholder Base
April 06, 2021 09:30 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, April 06, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom...
Optimi Health Large Scale Multi-Purpose Mushroom Facility Advances Towards Completion and Licensing
March 23, 2021 09:00 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, March 23, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused...
Optimi Health Receives Health Canada NPN Product Licenses in Preparation for Q2 Sales Launch
March 16, 2021 09:00 ET
|
Optimi Health Corp.
--Company Introduces Celebrity Wellness Expert Harley Pasternak as Advisor VANCOUVER, British Columbia, March 16, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (“Optimi” or the...
Optimi Health Accelerates Psilocybin Clinical Trial Program with IMPACT
March 09, 2021 09:00 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, March 09, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused...
OPTIMI HEALTH and NUMINUS WELLNESS to Conduct Psychedelic Lab Research and Development
March 02, 2021 09:00 ET
|
Optimi Health Corp.
Agreement propels development of safe and effective proprietary products and formulations for the emerging psychedelic industry VANCOUVER, British Columbia, March 02, 2021 (GLOBE NEWSWIRE) --...
Optimi Health Corp. Completes Oversubscribed $20.7 Million Initial Public Offering, and Announces Listing on the CSE
February 25, 2021 09:00 ET
|
Optimi Health Corp.
NOT FOR DISTRIBUTION IN THE UNITED STATES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (“Optimi” or the...
Optimi Health Corp. Receives Receipt For Final Prospectus and Conditional Approval to List on the CSE
February 18, 2021 15:18 ET
|
Optimi Health Corp.
NOT FOR DISTRIBUTION IN THE UNITED STATES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (“Optimi” or the “Company”),...
Optimi Health Corp. Receives Health Canada Psychedelic Research Exemption and Files Preliminary Prospectus for Initial Public Offering of Units
January 15, 2021 09:30 ET
|
Optimi Health Corp.
NOT FOR DISTRIBUTION IN THE UNITED STATES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Jan. 15, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (“Optimi” or the “Company”),...
Optimi Health Files Preliminary Non-Offering Prospectus
November 02, 2020 12:46 ET
|
Optimi Health Corp.
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Optimi Health Corp. (“Optimi” or the “Company”)...